project id: TCGA-BRCA; case submitter id: TCGA-EW-A1P0; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 8.9; spectrophotometer method: UV Spec; age at index: 55; days to birth: -20107; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1953; age at diagnosis: 20107; ajcc pathologic m: MX; ajcc pathologic n: N1b; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1251.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8523/3; primary diagnosis: Infiltrating duct mixed with other types of carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1142; days to sample procurement: 0; initial weight: 190.0; portion submitter id: TCGA-EW-A1P0-01A-11; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 35.0; percent tumor cells: 65.0; percent tumor nuclei: 75.0;